# Diagnosis and Treatment of Nontraumatic Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analyses for the ARCO Clinical Practice Guideline Development Workgroup

**Authors:** Romil R. Parikh, Alireza Mirzaei, Mary E. Butler, Diego J. Restrepo, Sergio F. Guarin Perez, Sallee Brandt, Gabrielle Swartz, Reza Katanbaf, Stuart B. Goodman, Michael A. Mont, Quanjun Cui, Lynne C. Jones, Edward Y. Cheng

PMC · DOI: 10.3390/medsci14010107 · 2026-02-23

## TL;DR

This review evaluates the best imaging and treatment options for nontraumatic osteonecrosis of the femoral head, highlighting MRI's accuracy and the need for better comparative studies.

## Contribution

The study provides a systematic review and meta-analyses to guide clinical practice for diagnosing and treating ONFH, emphasizing MRI's diagnostic superiority and gaps in treatment evidence.

## Key findings

- MRI has the highest sensitivity and specificity for diagnosing ONFH.
- Core decompression plus bone marrow concentrate may reduce femoral head collapse compared to core decompression alone.
- Evidence for treatment effectiveness is limited and mostly observational.

## Abstract

Background/Objectives: Diagnostic evaluation and management of nontraumatic osteonecrosis of the femoral head (ONFH) vary substantially. This systematic review was conducted to inform development of the Association Research Circulation Osseous (ARCO) clinical practice guideline for diagnosis and treatment of ARCO stages I to III ONFH. Methods: We searched MEDLINE, EMBASE, Web of Science, SCOPUS, Global Index Medicus, and the Cochrane Library for studies evaluating imaging modalities and treatments for adult ONFH. We assessed risk of bias using the QUADAS-2, the ROB-2, and the ROBINS-I tools; conducted meta-analyses using random-effects regression; and evaluated certainty of evidence using GRADE methodology. Results: Among 36 included studies, 18 addressed diagnostic test accuracy and 18 addressed comparative effectiveness of treatments. Magnetic resonance imaging (MRI) demonstrated the highest pooled sensitivity (0.91; 95% confidence interval (CI), 0.87 to 0.94) and specificity (0.96; 95% CI, 0.87 to 0.99) for ONFH diagnosis. Bone marrow edema and grade 2+ joint effusion on MRI differentiated symptomatic versus asymptomatic disease. Computed tomography and MRI better detected subchondral fractures than plain radiography. Very low-grade evidence suggested lower rates of femoral head collapse with core decompression plus bone marrow concentrate compared with core decompression alone (pooled relative risk [RR], 0.55; 95% CI, 0.36 to 0.83), and with vascularized versus non-vascularized bone grafting (RR, 0.35; 95% CI, 0.14 to 0.84) over a ≤5-year follow-up. Based on three non-comparative case series, osteotomies might have a lower risk of collapse over a 10- to 20-year follow-up, but this needs to be evaluated in future comparative research. Inconsistent outcome reporting hindered treatment outcome pooling. There were no comparative studies that evaluated observation only versus intervention in asymptomatic disease or strategies for monitoring treatment response. Conclusions: Evidence supporting optimal imaging modalities and early joint-preserving interventions remains limited and predominantly observational, underscoring the need for high-quality comparative studies with consistently defined core outcomes to guide clinical decision-making.

## Full-text entities

- **Diseases:** BME (MESH:D004487), fracture (MESH:D050723), inflammatory conditions (MESH:D007249), thrombosis (MESH:D013927), hemoglobinopathies (MESH:D006453), Subchondral Fracture (MESH:D001845), necrosis (MESH:D009336), bone failure (MESH:D000080983), ARCO stages I to III ONFH (MESH:C535395), systemic lupus (MESH:D008180), autoimmune disease (MESH:D001327), collapse (MESH:D001261), stages I to III disease (MESH:D007676), hip pain (MESH:D010146), Osteonecrosis of the Femoral Head (MESH:D000070603), idiopathic disease (MESH:D010300), Osteonecrosis (MESH:D010020), precollapse disease (MESH:D004194), effusion (MESH:D000080324), hip osteoarthritis (MESH:D015207), BS (MESH:D001847), I (MESH:D006969), ARCO (MESH:D014947), articular (MESH:D057072)
- **Chemicals:** alcohol (MESH:D000438), BMC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027876/full.md

---
Source: https://tomesphere.com/paper/PMC13027876